|
|
|
42
|
5693FF
|
VALOVERA 500MG TAB (JLP) VALACYCLOVIR
|
VALACYCLOVIR
|
VALOVERA
|
10X10
|
A
|
51.65
|
0.52
|
TAB
|
42
|
BLIS
|
JLP
|
JOHN LEE PHARMACEUTICALS
|
AHI
|
ARMSTRONG HEALTHCARE INC
|
|
081832
|
NUCLEOSIDES AND NUCLEOTIDES
|
2026-04-01
|
2028-03-31
|
|
ORAL
|
0
|
NUCLEOSIDES AND NUCLEOTIDES
|
|
|
|
|
40
|
5693S
|
VALTREX 500MG TAB (GSK/COL) VALACYCLOVIR
|
VALACYCLOVIR
|
VALTREX
|
42'S
|
C
|
251.61
|
5.99
|
TABLET
|
0
|
TAB
|
GSK
|
GLAXOSMITHKLINE
|
COL
|
COLLINS LTD
|
|
081832
|
NUCLEOSIDES AND NUCLEOTIDES
|
2022-04-01
|
2024-03-31
|
|
Oral
|
0
|
ANTI-INFECTIVE AGENTS
|
|
|
|
|
41
|
5693S
|
VALTREX 500MG TAB (GSK) VALACYCLOVIR (C)
|
VALACYCLOVIR
|
VALTREX
|
42'S
|
C
|
276.75
|
6.5893
|
TAB
|
42
|
BOX
|
GSK
|
GLAXOSMITHKLINE
|
COL
|
COLLINS LTD
|
|
081832
|
NUCLEOSIDES AND NUCLEOTIDES
|
2024-04-01
|
2026-03-31
|
|
ORAL
|
0
|
NUCLEOSIDES AND NUCLEOTIDES
|
|
|
|
|
42
|
5693S
|
VALTREX 500MG TAB (GSK) VALACYCLOVIR
|
VALACYCLOVIR
|
VALTREX
|
42'S
|
C
|
290.59
|
6.92
|
TAB
|
42
|
BLIS
|
GSK
|
GLAXOSMITHKLINE
|
COL
|
AVENTA BARBADOS
|
|
081832
|
NUCLEOSIDES AND NUCLEOTIDES
|
2026-04-01
|
2028-03-31
|
|
ORAL
|
0
|
NUCLEOSIDES AND NUCLEOTIDES
|
|
|
|
|
40
|
56944
|
ZOVIRAX 5% CR (GSK/COL) ACYCLOVIR
|
ACYCLOVIR
|
ZOVIRAX
|
5G
|
C
|
20.93
|
20.93
|
CREAM
|
0
|
TUBE
|
GSK
|
GLAXOSMITHKLINE
|
COL
|
COLLINS LTD
|
|
081832
|
NUCLEOSIDES AND NUCLEOTIDES
|
2022-04-01
|
2024-03-31
|
|
TOPICAL
|
0
|
ANTI-INFECTIVE AGENTS
|
|
|
|
|
41
|
56944
|
ZOVIRAX 5% CR (GSK) ACYCLOVIR (C)
|
ACYCLOVIR
|
ZOVIRAX
|
5G
|
C
|
23.02
|
23.0242
|
TUBE
|
2
|
BOX
|
GSK
|
GLAXOSMITHKLINE
|
COL
|
COLLINS LTD
|
|
081832
|
NUCLEOSIDES AND NUCLEOTIDES
|
2024-04-01
|
2026-03-31
|
|
TOPICAL
|
0
|
NUCLEOSIDES AND NUCLEOTIDES
|
|
|
|
|
42
|
56944
|
ZOVIRAX 5% CR (GSK) ACYCLOVIR
|
ACYCLOVIR
|
ZOVIRAX
|
5G
|
C
|
25.50
|
25.50
|
TUBE
|
2
|
BOX
|
GSK
|
GLAXOSMITHKLINE
|
COL
|
AVENTA BARBADOS
|
|
081832
|
NUCLEOSIDES AND NUCLEOTIDES
|
2026-04-01
|
2028-03-31
|
|
TOPICAL
|
0
|
NUCLEOSIDES AND NUCLEOTIDES
|
2026-02-16
|
|
|
|
40
|
56949
|
CYCLOVAX 5% CR (REM/SBI) ACYCLOVIR
|
ACYCLOVIR
|
CYCLOVAX
|
10G
|
A
|
3.07
|
3.07
|
CREAM
|
2
|
TUBE
|
REM
|
REMEDICA LTD
|
SBI
|
MASSY DISTRIBUTION (BDOS) LTD
|
|
081832
|
NUCLEOSIDES AND NUCLEOTIDES
|
2022-04-01
|
2024-03-31
|
|
TOPICAL
|
0
|
ANTI-INFECTIVE AGENTS
|
|
|
|
|
41
|
56949
|
CYCLOVAX 5% CR (REM) ACYCLOVIR
|
ACYCLOVIR
|
CYCLOVAX
|
10G
|
A
|
3.07
|
3.0717
|
TUBE
|
2
|
BOX
|
REM
|
REMEDICA LTD
|
SBI
|
MASSY DISTRIBUTION (BDOS) LTD
|
|
081832
|
NUCLEOSIDES AND NUCLEOTIDES
|
2024-04-01
|
2026-03-31
|
|
TOPICAL
|
0
|
NUCLEOSIDES AND NUCLEOTIDES
|
|
|
|
|
42
|
5694AF
|
ACYCLOVIR 5% CR (HEA)
|
ACYCLOVIR
|
ACYCLOVIR
|
5G
|
A
|
1.41
|
1.41
|
TUBE
|
2
|
TUBE
|
HEA
|
HEALTH 2000 INC
|
AHI
|
ARMSTRONG HEALTHCARE INC
|
|
081832
|
NUCLEOSIDES AND NUCLEOTIDES
|
2026-04-01
|
2028-03-31
|
|
TOPICAL
|
0
|
NUCLEOSIDES AND NUCLEOTIDES
|
|
|
|
|
42
|
5694AG
|
ACYCLOVIR 5% CR (CIR)
|
ACYCLOVIR
|
ACYCLOVIR
|
10G
|
A
|
3.67
|
3.67
|
TUBE
|
2
|
TUBE
|
CIR
|
CIRON PHARMA
|
CWS
|
CAPSULE WHOLESALE
|
|
0818
|
ANTIVIRALS
|
2026-04-01
|
2028-03-31
|
|
TOPICAL
|
0
|
ANTIVIRALS
|
|
|
|
|
42
|
5694AH
|
ACYCLOVIR 5% CR (HEA)
|
ACYCLOVIR
|
ACYCLOVIR
|
5G TUBE
|
A
|
1.41
|
1.41
|
TUBE
|
2
|
TUBE
|
HEA
|
HEALTH 2000 INC
|
CWS
|
CAPSULE WHOLESALE
|
|
081832
|
NUCLEOSIDES AND NUCLEOTIDES
|
2026-04-01
|
2028-03-31
|
|
TOPICAL
|
0
|
NUCLEOSIDES AND NUCLEOTIDES
|
2026-01-26
|
|
|
|
42
|
5694AJ
|
ACYCLOVIR 5% CR (FSB)
|
ACYCLOVIR
|
ACYCLOVIR
|
5G
|
A
|
1.09
|
1.09
|
TUBE
|
2
|
|
FSB
|
FLAGSHIP BIOTECH
|
STO
|
BRYDEN STOKES LTD
|
|
081832
|
NUCLEOSIDES AND NUCLEOTIDES
|
2026-04-01
|
2028-03-31
|
|
TOPICAL
|
0
|
NUCLEOSIDES AND NUCLEOTIDES
|
2026-03-05
|
|
|
|
42
|
5694AK
|
ACYCLOVIR 5% CR (HEA)
|
ACYCLOVIR
|
ACYCLOVIR
|
5G
|
A
|
1.41
|
1.41
|
TUBE
|
2
|
|
HEA
|
HEALTH 2000 INC
|
STO
|
BRYDEN STOKES LTD
|
|
081832
|
NUCLEOSIDES AND NUCLEOTIDES
|
2026-04-01
|
2028-03-31
|
|
TOPICAL
|
0
|
NUCLEOSIDES AND NUCLEOTIDES
|
2026-02-27
|
|
|
|
40
|
5694G
|
ACYCLOVIR 5% CR (HEA/RXP)
|
ACYCLOVIR
|
ACYCLOVIR
|
5G
|
A
|
2.58
|
2.58
|
CREAM
|
2
|
TUBE
|
HEA
|
HEALTH 2000 INC
|
RXP
|
RX PRO INC
|
|
081832
|
NUCLEOSIDES AND NUCLEOTIDES
|
2022-04-01
|
2024-03-31
|
|
TOPICAL
|
0
|
ANTI-INFECTIVE AGENTS
|
|
|
|
|
40
|
5694U
|
ACYCLOVIR 5% CR (KWA/ATB)
|
ACYCLOVIR
|
ACYCLOVIR
|
4G
|
A
|
2.31
|
2.31
|
CREAM
|
2
|
TUBE
|
KWA
|
KWALITY PHARMACEUTICALS
|
ATB
|
ANSA TRADING BARBADOS LTD
|
|
081832
|
NUCLEOSIDES AND NUCLEOTIDES
|
2022-04-01
|
2024-03-31
|
|
TOPICAL
|
0
|
ANTI-INFECTIVE AGENTS
|
|
|
|
|
40
|
5694Z
|
ACYCLOVIR 5% CR (HEA/ATB)
|
ACYCLOVIR
|
ACYCLOVIR
|
5G
|
A
|
2.58
|
2.58
|
CREAM
|
2
|
|
HEA
|
HEALTH 2000 INC
|
ATB
|
ANSA TRADING BARBADOS LTD
|
|
81832
|
NUCLEOSIDES AND NUCLEOTIDES
|
2022-07-12
|
2024-03-31
|
la
|
Topical
|
0
|
NUCLEOSIDES AND NUCLEOTIDES
|
2022-11-25
|
|
|
|
41
|
5694Z
|
ACYCLOVIR 5% CR (HEA)
|
ACYCLOVIR
|
ACYCLOVIR
|
5G
|
A
|
1.47
|
1.4679
|
TUBE
|
2
|
BOX
|
HEA
|
HEALTH 2000 INC
|
ATB
|
ANSA TRADING BARBADOS LTD
|
|
081832
|
NUCLEOSIDES AND NUCLEOTIDES
|
2024-04-01
|
2026-03-31
|
|
Topical
|
0
|
NUCLEOSIDES AND NUCLEOTIDES
|
|
|
|
|
40
|
56955
|
ACYVIR 3% EYE OINT (ARP/AHI) ACYCLOVIR
|
ACYCLOVIR
|
ACYVIR
|
5G
|
A
|
8.02
|
8.02
|
EYE OINTMENT
|
2
|
TUBE
|
ARP
|
ARISTOPHARMA LTD
|
AHI
|
ARMSTRONG HEALTHCARE INC
|
|
520420
|
EENT ANTIVIRALS
|
2022-04-01
|
2024-03-31
|
|
OPHTHALMIC
|
0
|
EYE, EAR, NOSE AND THROAT PREPARATIONS
|
|
|
|
|
41
|
56956
|
OPTIVIRAL 3% EYE OINT (SPC) ACYCLOVIR
|
ACYCLOVIR
|
OPTIVIRAL
|
5G
|
A
|
1.14
|
1.1417
|
TUBE
|
2
|
TUBE
|
SPC
|
SELVOK PHARMACEUTICALS CO
|
PSB
|
PHARMACEUTICAL SOLUTIONS BARBA
|
|
520420
|
EENT ANTIVIRALS
|
2024-04-01
|
2026-03-31
|
|
OPHTHALMIC
|
0
|
EENT ANTIVIRALS
|
|
